Acute demyelinating disorders of the central nervous system constitute a heterogeneous group of immune-mediated conditions characterised by rapid loss of the myelin sheath enveloping neuronal axons.

Demyelinating disorders constitute a diverse group of diseases in which the protective myelin sheath surrounding central nervous system axons is damaged by immune-mediated or inflammatory processes.

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design and patient-derived predictive ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell‐based therapies ...

NMOSD accounts for 1 to 2% of all cases of CNS inflammatory demyelinating disease in the United States and Europe, with multiple sclerosis being much more common, but NMOSD accounts for one third or ...

Demyelinating diseases are any conditions that damage the protective coating on nerve cells, the myelin sheath. Some common demyelinating diseases of the central nervous system include multiple ...

The Marburg variant of multiple sclerosis is extremely rare but also the most severe. Life expectancy has been weeks or months, but advances in treatment have led to an improved outlook. Multiple ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

The termination is an early setback to new chief executive Belen Garijo, who took the helm last month.

Sanofi (NASDAQ:SNY) said on Wednesday that it has decided to discontinue the phase 3 MOBILIZE trial evaluating riliprubart in ...